Loss of Borealin/DasraB leads to defective cell proliferation, p53 accumulation and early embryonic lethality-Reference-Cited by-同舟云学术

Loss of Borealin/DasraB leads to defective cell proliferation, p53 accumulation and early embryonic lethality

Published:2008-05 Issue:5-6 Volume:125 Page:441-450
ISSN:0925-4773
Container-title:Mechanisms of Development
language:en
Short-container-title:Mechanisms of Development

Author:

Yamanaka Yasunari,Heike Toshio,Kumada Tomohiro,Shibata Minoru,Takaoka Yuki,Kitano Ayumi,Shiraishi Kazuhiro,Kato Takeo,Nagato Masako,Okawa Katsuya,Furushima Kenryo,Nakao Kazuki,Nakamura Yukio,Taketo Makoto Mark,Aizawa Shinichi,Nakahata Tatsutoshi

Publisher

Elsevier BV

Subject

Developmental Biology,Embryology

Reference33 articles.

1. Chromosomal passengers and the (aurora) ABCs of mitosis;Adams;Trends Cell Biol.,2001

2. ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage;Aladjem;Curr. Biol.,1998

3. Mitotic mechanics: the auroras come into view;Andrews;Curr. Opin. Cell Biol.,2003

4. The cellular geography of aurora kinases;Carmena;Nat. Rev. Mol. Cell Biol.,2003

5. Survivin is required for stable checkpoint activation in taxol-treated HeLa cells;Carvalho;J. Cell Sci.,2003

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcription factor E2F4 facilitates SUMOylation to promote HCC progression through interaction with LIN9;International Journal of Oncology;2024-09-02

2. Role of cell division cycle-associated proteins in regulating cell cycle and promoting tumor progression;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

3. Borealin/CDCA8 deficiency alters thyroid development and results in papillary tumor-like structures;Frontiers in Endocrinology;2023-10-27

4. A 1-kb human CDCA8 promoter directs the spermatogonia-specific luciferase expression in adult testis;Gene;2023-05

5. CDCA8 induced by NF-YA promotes hepatocellular carcinoma progression by regulating the MEK/ERK pathway;Experimental Hematology & Oncology;2023-01-13